Antisense therapy in oncology: new hope for an old idea?
about
Silencing the epidermal growth factor receptor gene with RNAi may be developed as a potential therapy for non small cell lung cancer.Ru-TAP complexes and DNA: from photo-induced electron transfer to gene photo-silencing in living cellsMYC activation is a hallmark of cancer initiation and maintenanceOligonucleotides and derivatives as gene-specific control agents.A novel concept for ligand attachment to oligonucleotides via a 2'-succinyl linker.The characterization of cationic fusogenic liposomes mediated antisense oligonucleotides into HeLa cells.Inactivation of MYC reverses tumorigenesis.Targeted therapies for pancreatic cancer.Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.Layer-by-layer assembled antisense DNA microsponge particles for efficient delivery of cancer therapeutics.Persistent gamma-herpesvirus infections: what can we learn from an experimental mouse model?Overview of the clinical efficacy of investigational anticancer drugs.Transcription factor decoy (TFD) in breast cancer research and treatment.Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.Strategies for reversing drug resistance.Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors.Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis.Role of Toll-like receptors in antisense and siRNA [corrected].TGF-beta inhibitors for the treatment of cancer.Advances in the treatment for haematological malignancies.New perspectives on the treatment of differentiated thyroid cancer.2'-Fluoroarabino- and arabinonucleic acid show different conformations, resulting in deviating RNA affinities and processing of their heteroduplexes with RNA by RNase HDownregulation of KSR1 in pancreatic cancer xenografts by antisense oligonucleotide correlates with tumor drug uptake.Effective delivery of antisense peptide nucleic acid oligomers into cells by anthrax protective antigenThe Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer MetastasisBiological barriers to therapy with antisense and siRNA oligonucleotides.Beyond oncology--application of HPMA copolymers in non-cancerous diseases.Bioanalytical LC-MS of therapeutic oligonucleotides.Quantum rods as nanocarriers of gene therapy.5'-,3'-inverted thymidine-modified antisense oligodeoxynucleotide targeting midkine. Its design and application for cancer therapy.CREB regulates AChE-R-induced proliferation of human glioblastoma cells.Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting.Down-regulation of heparanase leads to the inhibition of invasion and proliferation of A549 cells in vitro and in vivo.Therapeutic potential of antisense oligodeoxynucleotides in downregulating p53 oncogenic mutations in cancers.Emerging Gene Therapies for Genetic Hearing Loss.Controlled expression of an rpoS antisense RNA can inhibit RpoS function in Escherichia coli.Nanostructure of cationic lipid-oligonucleotide complexes.Antisense oligonucleotide technologies in drug discovery.Antisense downregulation of mutant huntingtin in a cell model.Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.
P2860
Q24814041-25D12B29-6A56-45C1-8892-3AC6339BDCF0Q27014967-10BE9604-4E60-4362-83DE-3A1DFDB8F13BQ27026026-D264E945-5C7F-4C8E-917B-C775DDCACE7CQ31013431-E4EDA317-F6FE-4579-B3B8-35BBD67CB8E4Q33197337-966B2A86-7A63-4AC7-9521-2B13B9B807E9Q33201731-BC959742-9AE2-4E28-8D56-D6FBA9E34EADQ33784668-0299D7D0-334F-412B-9750-C3D9B750CC63Q33899923-BBB36314-1C41-440F-A376-CB46D9DBF614Q34366036-126E2BE5-422E-4A3F-B985-CF1551CAE2E3Q34419904-F4FF917E-6976-41CF-BAE8-91DC5E83CE8CQ34584067-EB6CBCD3-A5BE-405E-A369-711BED79AB1BQ35067125-4CEDC5D2-47B8-47E2-B47B-B7DE6D734AF8Q35081110-E815C5DD-1B79-437E-8DEE-DF565E2A7566Q35166852-36038274-603A-44C7-9577-6389F9E2F30AQ35567287-B0AA575C-A387-40A6-9BBD-AFB0918C962AQ35609713-018F851F-3587-4D79-BBBB-62F0FF79E476Q35865494-35C19D51-6F13-4FD6-8FAB-5724626331A7Q35975656-FAFD72C4-B281-4553-8817-15B600B582C5Q36187040-11A88D33-122D-4623-A6AE-9017B949EEEAQ36429723-D84E7696-3E2F-421A-A1C7-4A649C2A5E61Q36904500-396E1A9F-9EC8-4944-AF74-89B2D1283273Q36908756-EA56B64F-8F1F-4B8D-A04C-0F8C4A0B9A68Q36957167-129259AE-30DA-4B9C-95DD-6401475A9242Q36968203-54C5C5D1-C3E4-49F1-9ABA-9D661BC64F8FQ36985643-1BEB6B87-CFEC-4462-8658-42335B23FB6BQ37378340-3FBC84C8-210B-4DBC-8948-0BAEF87C279DQ37631869-9E74FC2E-20C4-46ED-8A79-EF22AB0ED060Q37851144-83D0308F-41EF-4A66-9655-E2E22033AB67Q38014158-08BD6C3A-F226-4BCB-9176-845A3A9C28BFQ38290099-5671BA65-B591-4553-8036-77E961D1291FQ38340977-5184B838-BD4E-4572-B9AC-8D4C8A798EDAQ38972263-85A7CFF0-7113-4AA0-84DF-1E96FC6E0AAFQ39225944-9DC1609E-232B-48BF-9538-E8A5B8554CF5Q39649773-EDF76365-81AB-47C9-B6B0-084D57B10796Q40080564-7F6E6C2E-9CAB-49E8-A1FB-DED243BF326FQ40130460-5E10A28E-61BF-427C-B440-CC26B6A48D46Q40289072-0225EFB6-2EFA-4B9C-A673-98C7DE29C5A1Q40292829-AFE85DE2-AB92-48D5-8D8C-51B561B12888Q40641130-BFC5B2E3-BD30-4275-BD8E-BB213C317144Q41721643-CB700BC8-9C8E-452C-A1F2-EAB09DA2BA58
P2860
Antisense therapy in oncology: new hope for an old idea?
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antisense therapy in oncology: new hope for an old idea?
@ast
Antisense therapy in oncology: new hope for an old idea?
@en
Antisense therapy in oncology: new hope for an old idea?
@nl
type
label
Antisense therapy in oncology: new hope for an old idea?
@ast
Antisense therapy in oncology: new hope for an old idea?
@en
Antisense therapy in oncology: new hope for an old idea?
@nl
prefLabel
Antisense therapy in oncology: new hope for an old idea?
@ast
Antisense therapy in oncology: new hope for an old idea?
@en
Antisense therapy in oncology: new hope for an old idea?
@nl
P1433
P1476
Antisense therapy in oncology: new hope for an old idea?
@en
P304
P356
10.1016/S0140-6736(01)05629-X
P407
P577
2001-08-01T00:00:00Z